Skip to main content
. 2008 Feb 19;105(8):2865–2870. doi: 10.1073/pnas.0712391105

Fig. 2.

Fig. 2.

Expression of IL-32 in primary marrow-derived stroma cells from untreated patients with CMML (n = 6) or MDS (n = 13) and healthy control subjects (n = 6). mRNA levels were determined by quantitative RT-PCR. P values are in comparison with healthy subjects. IL-32 levels were significantly lower in patients with CMML (P = 0.01) and higher in patients with MDS (P = 0.014).